Table 2. Target lesion features as risk factors for prolonged chest tube requirement post percutaneous lung biopsy.
Chest tube dwell time <3 days post- biopsy | Chest tube dwell time ≥3 days post-biopsy | p-value | |
---|---|---|---|
| |||
Total (n) | 132 | 55 | |
| |||
Lesion Diameter (mm) | |||
Median | 17.0 | 17.5 | p = 0.59 |
Range | 8.0–63.0 | 5.0–61.0 | |
| |||
Lesion distance from pleura along needle path (mm) | |||
Median | 32.0 | 29.0 | p = 0.64 |
Range | 0.0–113.0 | 0.0–83.0 | |
| |||
Lesion distance from pleura along needle path (mm) | |||
Median | 78.5 | 73.0 | p = 0.72 |
Range | 0.0–155.0 | 0.0–146.0 | |
| |||
Right vs. left lung | |||
% R (n) | 60% (80) | 46% (25) | p = 0.10 |
| |||
Lobe | |||
% Left Upper (n) | 33.8% (26) | 43.5% (10) | p = 0.20 |
% Left Lower (n) | 5.2% (4) | 17.4% (4) | |
% Right Upper (n) | 42.9% (33) | 26.1% (6) | |
% Right Middle (n) | 6.4% (5) | 8.7% (2) | |
% Right Lower (n) | 11.7% (9) | 4.3% (1) | |
| |||
Tissue diagnosis | |||
% Non-diagnostic | 3.0% (4) | 3.6% (2) | p = 0.77 |
% Benign | 21.1% (28) | 25.5% (14) | |
% Malignant | 75.9% (100) | 70.9% (39) | |
| |||
Primary vs. metastatic | |||
% Pathologic diagnosis suggestive of metastasis (n) | 21% (19) | 24% (8) | p = 0.80 |
| |||
Lung Primary Subtypes | p = 0.30 | ||
% Adenocarcinoma (n) | 84.5% (59) | 79.2% (19) | |
% Squamous (n) | 14.1% (10) | 12.5% (3) | |
% Small Cell (n) | 0% (0) | 4.2% (1) | |
% Mesothelioma (n) | 1.4% (1) | 4.2% (1) |